11-119107901-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001290474.2(C2CD2L):āc.160G>Cā(p.Gly54Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00004 in 1,525,150 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001290474.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C2CD2L | ENST00000648610.2 | c.160G>C | p.Gly54Arg | missense_variant | 1/14 | NM_001290474.2 | ENSP00000497391.1 | |||
C2CD2L | ENST00000336702.7 | c.160G>C | p.Gly54Arg | missense_variant | 1/14 | 1 | ENSP00000338885.3 | |||
DPAGT1 | ENST00000409993.6 | c.-1122C>G | 5_prime_UTR_variant | 1/11 | 2 | ENSP00000386597.2 |
Frequencies
GnomAD3 genomes AF: 0.0000264 AC: 4AN: 151752Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000168 AC: 2AN: 118796Hom.: 0 AF XY: 0.0000293 AC XY: 2AN XY: 68374
GnomAD4 exome AF: 0.0000415 AC: 57AN: 1373398Hom.: 0 Cov.: 32 AF XY: 0.0000441 AC XY: 30AN XY: 679906
GnomAD4 genome AF: 0.0000264 AC: 4AN: 151752Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74102
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 21, 2024 | The c.160G>C (p.G54R) alteration is located in exon 1 (coding exon 1) of the C2CD2L gene. This alteration results from a G to C substitution at nucleotide position 160, causing the glycine (G) at amino acid position 54 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at